Clinical Trial Update: Assessing Portal Hypertension With Methacetin Breath Test [NA]

View source ↗

Summary

Clinical trial assessing portal hypertension using the methacetin breath test in patients with compensated liver cirrhosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Compensated Liver Cirrhosis

Drugs mentioned

• Methacetin Breath Test (methacetin breath test)

Snippet

Sponsor: Meridian Bioscience, Inc. | Conditions: Patients With Compensated Liver Cirrhosis | NA | Status: COMPLETED | Results posted: 2019-09-19